Stay updated on LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a system/template update with no changes to study details.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision label on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedPulmonary fibrosis is listed as a condition, and a Genetic and Rare Diseases Information Center resource link has been added.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page shows a minor revision/version label change from v3.4.1 to v3.4.2, which does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange Detected- The page footer now shows Revision: v3.4.1, replacing v3.4.0. This is a minor site update that does not affect study content or user actions.SummaryDifference0.1%

- Check62 days agoChange DetectedGlossary display toggle added and footer/version text updated to Revision: v3.4.0 with No FEAR Act Data. The previous wording/casing (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LASN01 Safety & Pharmacokinetics in Pulmonary Fibrosis Clinical Trial page.